ANRO
Price
$3.88
Change
+$0.08 (+2.11%)
Updated
Sep 26, 12:57 PM (EDT)
Capitalization
102.89M
53 days until earnings call
IRON
Price
$63.41
Change
+$0.92 (+1.47%)
Updated
Sep 26, 01:07 PM (EDT)
Capitalization
2.17B
41 days until earnings call
Interact to see
Advertisement

ANRO vs IRON

Header iconANRO vs IRON Comparison
Open Charts ANRO vs IRONBanner chart's image
Alto Neuroscience
Price$3.88
Change+$0.08 (+2.11%)
Volume$300
Capitalization102.89M
Disc Medicine
Price$63.41
Change+$0.92 (+1.47%)
Volume$100
Capitalization2.17B
ANRO vs IRON Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. IRON commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a StrongBuy and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ANRO: $3.80 vs. IRON: $62.50)
Brand notoriety: ANRO and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 53% vs. IRON: 69%
Market capitalization -- ANRO: $102.89M vs. IRON: $2.17B
ANRO [@Biotechnology] is valued at $102.89M. IRON’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANRO and IRON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 2 TA indicator(s) are bullish while IRON’s TA Score has 4 bullish TA indicator(s).

  • ANRO’s TA Score: 2 bullish, 6 bearish.
  • IRON’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а -7.54% price change this week, while IRON (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

ANRO is expected to report earnings on Nov 18, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.17B) has a higher market cap than ANRO($103M). IRON YTD gains are higher at: -1.420 vs. ANRO (-10.165). ANRO has higher annual earnings (EBITDA): -62.3M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. ANRO (148M). ANRO has less debt than IRON: ANRO (27.3M) vs IRON (30.9M). ANRO (0) and IRON (0) have equivalent revenues.
ANROIRONANRO / IRON
Capitalization103M2.17B5%
EBITDA-62.3M-142.42M44%
Gain YTD-10.165-1.420716%
P/E RatioN/AN/A-
Revenue00-
Total Cash148M650M23%
Total Debt27.3M30.9M88%
TECHNICAL ANALYSIS
Technical Analysis
ANROIRON
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVKIX20.38N/A
N/A
VY® Invesco Comstock I
LFEIX24.35N/A
N/A
Federated Hermes Equity Income F
FNKCX16.45N/A
N/A
Frank Value C
MMFFX15.05N/A
N/A
MM S&P 500® Index A
FSGGX18.16N/A
N/A
Fidelity Global ex US Index

ANRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANRO has been loosely correlated with NUVL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANRO jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
-2.06%
NUVL - ANRO
34%
Loosely correlated
-2.54%
XTLB - ANRO
27%
Poorly correlated
-0.83%
NTLA - ANRO
25%
Poorly correlated
-6.48%
CRSP - ANRO
24%
Poorly correlated
-1.20%
IRON - ANRO
24%
Poorly correlated
+0.18%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.18%
NUVL - IRON
54%
Loosely correlated
-2.54%
KMSTF - IRON
54%
Loosely correlated
N/A
SYRE - IRON
53%
Loosely correlated
-8.18%
CGON - IRON
51%
Loosely correlated
-0.55%
XNCR - IRON
50%
Loosely correlated
-1.34%
More